Bupivacaine
DrugCaudal Bupivacaine 2 mg/kg single shot
Other names: Broup B
NCT Number: NCT02385435
The aim of this prospective randomized double-blind study was to compare the analgesic efficacy and the side effects of two doses of dexmedetomidine (1 and 2 µg.kg-1) co-administered with bupivacaine with bupivacaine alone for caudal analgesia in children undergoing infra-umbilical surgery.
Looking for future studies?
Notify Me1 year–6 year
All sexes
Interventional
Phase 2 / Phase 3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Caudal Bupivacaine 2 mg/kg single shot
Other names: Broup B
Caudal dexmedetomidine 1μg.kg-1, single shot
Other names: Group BD1
Caudal dexmedetomidine 2μg.kg-1, single shot
Other names: Group BD2
Time frame: 24 hours
The time from end of surgery to the first requirement of postoperative analgesia
Time frame: 24 hours
Time frame: 24 hours
Number of paracetamol doses needed by each patient
Time frame: 2 hours
Level of sedation was recorded throughout the post-anesthesia care unit stay at 15-minute time intervals.
Time frame: intraoperative
Sevoflurane concentration required to maintain Bispectral Index (BIS) monitor reading between 40 and 60%.
Time frame: intraoperative
Intraoperative blood pressure readings
Time frame: intraoperative
Intraoperative heart rate readings
Time frame: 24 hours
Any side effects of study drugs in the first 24 hours postoperative hours were recorded (nausea, Vomiting, urine retention, lower limb weakness and emesis).
University of Jordan
Other
Comparison of Caudal Bupivacaine Alone With Bupivacaine Plus Two Doses of Dexmedetomidine for Postoperative Analgesia in Pediatric Patients Undergoing Infra-umbilical Surgery: A Randomized Controlled Double Blinded Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05859061
Neurologic Manifestations, Pain
Chicago, Illinois, United States
View Trial DetailsNCT06791577
Blood Coagulation Disorders, Bruising
São Paulo, Brazil
View Trial DetailsNCT03090776
Neurologic Manifestations, Pain
Boston, Massachusetts, United States
View Trial Details